These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 174834)
1. The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects. Sancho J; Re R; Burton J; Barger AC; Haber E Circulation; 1976 Mar; 53(3):400-5. PubMed ID: 174834 [TBL] [Abstract][Full Text] [Related]
2. The role of the renin--angiotensin--aldosterone system in cardiovascular homeostasis in normal man. Haber E; Sancho J; Re R; Burton J; Barger AC Clin Sci Mol Med Suppl; 1975 Jun; 2():49s-52s. PubMed ID: 1077790 [TBL] [Abstract][Full Text] [Related]
3. Renin--angiotensin antagonists and the regulation of blood pressure. Samuels AI; Miller ED; Fray JC; Haber E; Barger AC Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095 [TBL] [Abstract][Full Text] [Related]
4. Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. Wong PY; Talamo RC; Williams GH; Colman RW J Clin Invest; 1975 Apr; 55(4):691-8. PubMed ID: 235559 [TBL] [Abstract][Full Text] [Related]
5. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363 [TBL] [Abstract][Full Text] [Related]
6. Relationship between aldosterone and bradykinin. Mersey JH; Williams GH; Hollenberg NK; Dluhy RG Circ Res; 1977 May; 40(5 Suppl 1):I84-8. PubMed ID: 870233 [TBL] [Abstract][Full Text] [Related]
7. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. Watkins L; Burton JA; Haber E; Cant JR; Smith FW; Barger AC J Clin Invest; 1976 Jun; 57(6):1606-17. PubMed ID: 180056 [TBL] [Abstract][Full Text] [Related]
8. [Renin and aldosterone secretion under converting enzyme inhibition]. Nakamura K Nihon Naibunpi Gakkai Zasshi; 1983 Aug; 59(8):1099-116. PubMed ID: 6141075 [TBL] [Abstract][Full Text] [Related]
9. The effects of saralasin, an angiotensin II antagonist, on blood pressure and the renin-angiotensin-aldosterone system in normal and hypertensive subjects. Brown JJ; Brown WC; Fraser R; Lever AF; Morton JJ; Robertson JI; Rosei EA; Trust PM Aust N Z J Med; 1976 Aug; 6(3 Suppl):48-52. PubMed ID: 1071403 [TBL] [Abstract][Full Text] [Related]
10. Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients. Millar JA; McGrath BP; Matthews PG; Johnston CI Clin Sci (Lond); 1981 Jul; 61(1):75-83. PubMed ID: 7018813 [TBL] [Abstract][Full Text] [Related]
11. Role of the renin-angiotensin system in the adaptation of aldosterone biosynthesis to sodium restriction in the rat. Tarján E; Spät A; Balla T; Székely A Acta Endocrinol (Copenh); 1980 Jul; 94(3):381-8. PubMed ID: 6158822 [TBL] [Abstract][Full Text] [Related]
12. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers. Shepherd AN; Campbell BC; Reid JL J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933 [TBL] [Abstract][Full Text] [Related]
13. George C. Griffith lecture. The role of renin in normal and pathological cardiovascular homeostasis. Haber E Circulation; 1976 Dec; 54(6):849-61. PubMed ID: 791534 [TBL] [Abstract][Full Text] [Related]
14. Regulation of aldosterone secretion by the renin-angiotensin system during sodium restriction in rats. Aguilera G; Catt KJ Proc Natl Acad Sci U S A; 1978 Aug; 75(8):4057-61. PubMed ID: 211515 [TBL] [Abstract][Full Text] [Related]
15. Studies of the control of plasma aldosterone concentration in normal man. I. Response to posture, acute and chronic volume depletion, and sodium loading. Williams GH; Cain JP; Dluhy RG; Underwood RH J Clin Invest; 1972 Jul; 51(7):1731-42. PubMed ID: 4338121 [TBL] [Abstract][Full Text] [Related]
16. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903 [TBL] [Abstract][Full Text] [Related]
17. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency. McCaa RE Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226 [TBL] [Abstract][Full Text] [Related]
18. The effect of the converting enzyme inhibitor SQ 20.881 on kinins, renin-angiotensin-aldosterone and catecholamines in relation to blood pressure in hypertensive patients. Hulthén L; Hökfelt B Acta Med Scand; 1978; 204(6):497-502. PubMed ID: 735881 [TBL] [Abstract][Full Text] [Related]
19. Dopaminergic suppression of angiotensin II-induced aldosterone secretion in man: differential responses during sodium loading and depletion. Drake CR; Ragsdale NV; Kaiser DL; Carey RM Metabolism; 1984 Aug; 33(8):696-702. PubMed ID: 6379373 [TBL] [Abstract][Full Text] [Related]
20. Evidence for a dual action of converting enzyme inhibitor on blood pressure in normal man. Goldstone R; Martin K; Zipser R; Horton R Prostaglandins; 1981 Oct; 22(4):587-98. PubMed ID: 6275456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]